Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Free Cash Flow Yield: 5.74%

Is the free cash flow yield high or low?

The free cash flow yield of 5.74% is 20% below its 5-year average of 7.19%, near the low end of its 5-year range (3.68%–12.35%).

As of Friday, June 26, 2026. 7.68% below its 12-month average of 6.22%.

DGX Free Cash Flow Yield

DGX Free Cash Flow Yield Chart

5.74%
+9.75% 1Y
DGX Free Cash Flow Yield

DGX Average Free Cash Flow Yield Chart

DGX Free Cash Flow Yield

DGX Current vs Average Free Cash Flow Yield Chart

DGX Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

5.74%

FREE CASH FLOW YIELD AVG TTM

6.22%

FREE CASH FLOW YIELD AVG 3Y

5.76%

FREE CASH FLOW YIELD AVG 5Y

7.19%

FREE CASH FLOW YIELD AVG 10Y

6.69%

FREE CASH FLOW YIELD AVG 15Y

7.00%

FREE CASH FLOW YIELD AVG 20Y

7.28%

CURRENT VS TTM AVG

-7.68%

CURRENT VS 3Y AVG

-0.35%

CURRENT VS 5Y AVG

-20.14%

CURRENT VS 10Y AVG

-14.20%

CURRENT VS 15Y AVG

-17.97%

CURRENT VS 20Y AVG

-21.19%

DGX Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B5.74%6.22%5.76%7.19%
BioNTech SE (BNTX)vs ›$22.76B6.57%4.16%18.36%19.65%
United Therapeutics Corporation (UTHR)vs ›$23.07B3.97%5.16%5.77%5.81%
Labcorp Holdings Inc. (LH)vs ›$22.08B6.27%5.82%5.23%7.15%
Incyte Corporation (INCY)vs ›$21.48B6.52%5.87%4.29%4.08%
Waters Corporation (WAT)vs ›$24.57B0.85%2.74%2.65%2.68%
STERIS plc (STE)vs ›$20.52B4.69%3.91%3.13%2.69%
Mettler-Toledo International Inc. (MTD)vs ›$25.24B3.15%3.21%3.25%2.89%
Veeva Systems Inc. (VEEV)vs ›$25.68B6.27%3.73%3.14%2.79%
Moderna, Inc. (MRNA)vs ›$26.45BN/A8.49%9.09%9.09%

Yield Comparison

FCF Yield

5.74%

Earnings Yield

4.39%

Dividend Yield

1.58%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow Yield FAQ

What is the free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The free cash flow yield for DGX stock is 5.74%.
Is Quest Diagnostics Incorporated's free cash flow yield high or low?
The free cash flow yield of 5.74% is 20% below its 5-year average of 7.19%, near the low end of its 5-year range (3.68%–12.35%).
What is the TTM average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The TTM average free cash flow yield for DGX stock is 6.22%.
What is the 3Y average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The 3Y average free cash flow yield for DGX stock is 5.76%.
What is the 5Y average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The 5Y average free cash flow yield for DGX stock is 7.19%.
What is the 10Y average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The 10Y average free cash flow yield for DGX stock is 6.69%.
What is the 15Y average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The 15Y average free cash flow yield for DGX stock is 7.00%.
What is the 20Y average free cash flow yield for Quest Diagnostics Incorporated (DGX)?
The 20Y average free cash flow yield for DGX stock is 7.28%.

DGX Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-255.74%
2026-06-245.83%
2026-06-236.01%
2026-06-226.12%
2026-06-186.07%
2026-06-175.99%
2026-06-165.89%
2026-06-155.85%
2026-06-125.83%
2026-06-115.81%
2026-06-105.81%
2026-06-095.79%
2026-06-086.00%
2026-06-055.91%
2026-06-046.04%
2026-06-036.11%
2026-06-026.13%
2026-06-016.16%
2026-05-296.08%
2026-05-286.04%
2026-05-276.10%
2026-05-266.14%
2026-05-226.06%
2026-05-216.11%
2026-05-206.11%
2026-05-196.22%
2026-05-186.24%
2026-05-156.35%
2026-05-146.30%
2026-05-136.20%
2026-05-126.23%
2026-05-116.24%
2026-05-086.32%
2026-05-076.20%
2026-05-066.26%
2026-05-056.20%
2026-05-046.18%
2026-05-016.15%
2026-04-306.10%
2026-04-296.25%
2026-04-286.07%
2026-04-276.02%
2026-04-246.03%
2026-04-235.93%
2026-04-225.80%
2026-04-215.92%
2026-04-206.18%
2026-04-176.22%
2026-04-166.34%
2026-04-156.34%
2026-04-146.25%
2026-04-136.29%
2026-04-106.34%
2026-04-096.13%
2026-04-086.11%
2026-04-076.17%
2026-04-066.10%
2026-04-026.13%
2026-04-016.14%
2026-03-316.19%
2026-03-306.15%
2026-03-276.21%
2026-03-266.12%
2026-03-256.18%
2026-03-246.19%
2026-03-236.20%
2026-03-206.22%
2026-03-196.25%
2026-03-186.22%
2026-03-176.11%
2026-03-166.10%
2026-03-136.08%
2026-03-126.04%
2026-03-116.05%
2026-03-106.04%
2026-03-096.02%
2026-03-066.09%
2026-03-055.95%
2026-03-045.82%
2026-03-035.82%
2026-03-025.77%
2026-02-275.73%
2026-02-265.75%
2026-02-255.93%
2026-02-245.88%
2026-02-235.94%
2026-02-206.09%
2026-02-196.09%
2026-02-186.03%
2026-02-176.00%
2026-02-135.96%
2026-02-125.96%
2026-02-115.89%
2026-02-106.00%
2026-02-096.45%
2026-02-066.46%
2026-02-056.41%
2026-02-046.51%
2026-02-036.66%
2026-02-026.66%
2026-01-306.59%
2026-01-296.76%
2026-01-286.75%
2026-01-276.69%
2026-01-266.75%
2026-01-236.81%
2026-01-226.77%
2026-01-216.68%
2026-01-206.52%
2026-01-166.51%
2026-01-156.48%
2026-01-146.60%
2026-01-136.85%
2026-01-127.01%
2026-01-097.07%
2026-01-086.93%
2026-01-076.92%
2026-01-066.83%
2026-01-057.11%
2026-01-027.09%
2025-12-317.10%
2025-12-307.02%
2025-12-297.02%
2025-12-267.01%
2025-12-247.01%
2025-12-237.04%
2025-12-226.99%
2025-12-197.00%
2025-12-187.00%
2025-12-176.88%
2025-12-166.90%
2025-12-156.70%
2025-12-126.75%
2025-12-116.79%
2025-12-106.87%
2025-12-096.86%
2025-12-086.78%
2025-12-056.75%
2025-12-046.69%
2025-12-036.75%
2025-12-026.75%
2025-12-016.71%
2025-11-286.51%
2025-11-266.50%
2025-11-256.41%
2025-11-246.47%
2025-11-216.45%
2025-11-206.57%
2025-11-196.63%
2025-11-186.65%
2025-11-176.62%
2025-11-146.59%
2025-11-136.57%
2025-11-126.60%
2025-11-116.53%
2025-11-106.69%
2025-11-076.87%
2025-11-066.98%
2025-11-056.92%
2025-11-046.93%
2025-11-036.89%
2025-10-317.01%
2025-10-307.01%
2025-10-297.05%
2025-10-286.92%
2025-10-276.84%
2025-10-246.77%
2025-10-236.73%
2025-10-226.80%
2025-10-216.68%
2025-10-205.69%
2025-10-175.71%
2025-10-165.80%
2025-10-155.78%
2025-10-145.84%
2025-10-135.93%
2025-10-105.89%
2025-10-095.97%
2025-10-085.99%
2025-10-075.96%
2025-10-066.07%
2025-10-036.04%
2025-10-025.98%
2025-10-015.95%
2025-09-305.69%
2025-09-295.74%
2025-09-265.73%
2025-09-255.84%
2025-09-245.80%
2025-09-235.79%
2025-09-225.87%
2025-09-195.90%
2025-09-185.91%
2025-09-175.94%
2025-09-166.01%
2025-09-156.00%
2025-09-125.92%
2025-09-115.90%
2025-09-106.01%
2025-09-095.93%
2025-09-085.93%
2025-09-055.90%
2025-09-046.01%
2025-09-036.04%
2025-09-026.06%
2025-08-295.96%
2025-08-286.05%
2025-08-276.02%
2025-08-266.01%
2025-08-256.06%
2025-08-226.01%
2025-08-215.90%
2025-08-205.88%
2025-08-195.92%
2025-08-186.05%
2025-08-156.02%
2025-08-146.07%
2025-08-136.05%
2025-08-126.06%
2025-08-116.07%
2025-08-086.12%
2025-08-076.22%
2025-08-066.26%
2025-08-056.25%
2025-08-046.28%
2025-08-016.34%
2025-07-316.47%
2025-07-306.42%
2025-07-296.45%
2025-07-286.45%
2025-07-256.43%
2025-07-246.30%
2025-07-236.35%
2025-07-225.24%
2025-07-215.61%
2025-07-185.60%
2025-07-175.56%
2025-07-165.60%
2025-07-155.61%
2025-07-145.55%
2025-07-115.56%
2025-07-105.45%
2025-07-095.38%
2025-07-085.42%
2025-07-075.37%
2025-07-035.28%
2025-07-025.29%
2025-07-015.21%
2025-06-305.20%
2025-06-275.25%
2025-06-265.28%
2025-06-255.23%
2025-06-245.19%
2025-06-235.20%
2025-06-205.21%
2025-06-185.20%
2025-06-175.22%
2025-06-165.13%
2025-06-135.19%
2025-06-125.22%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis